How to Start a Pharmaceutical Product Trading Business Outside the UAE from Dubai

How to Start a Pharmaceutical Product Trading Business Outside the UAE from Dubai

The parenthesis in the name is the activity. Trading In Pharmaceutical product (Outside UAE) is permission to buy and sell medicines that never arrive here — sourced in one country, delivered to another, and contracted, financed and coordinated from a desk in Dubai. The goods may pass through a port under customs control or may never touch the Gulf at all. What is being licensed is the trade rather than the product.

That is a real business and a large one, and the reason it concentrates here is unglamorous. A medicines trade between, say, a European or Indian manufacturer and a ministry of health in East Africa or Central Asia needs somebody in the middle who can be paid reliably, who can issue and accept documentary credit, who can be sued in a jurisdiction both ends accept, and who can reach either party inside one working day. Dubai supplies all four, plus freight connections to both ends and a long-established role in regional and humanitarian supply. A trading company here is selling access to that position as much as it is selling medicine.

What the licence does not do is the half most people get wrong, and it is worth stating before anything else: it does not make the UAE's rules irrelevant and it does not make anybody else's go away. The two permissions that actually govern every shipment belong to the country the goods leave and the country they enter. Neither is a UAE question, neither is in anybody's gift here, and both land commercially on the trader in the middle.

Who is this for?

The sourcing intermediary finds product for a buyer who cannot or will not deal directly with manufacturers — because the volumes are small, the market is unfamiliar, or the buyer needs several producers consolidated into one order. The value added is knowing who makes what and at what quality, and the income is a margin or a commission on goods the company may never physically see.

The manufacturer's regional desk is the opposite arrangement: a producer abroad wants a presence that handles the region's buyers, documentation and freight without opening a subsidiary in each market. The desk is effectively an export department with its own licence.

The institutional and tender supplier sells to ministries of health, state procurement agencies and large hospital groups in other countries. These are documentary, competitive, slow-paying contracts where the bid documents matter more than the relationship and the working capital requirement is the main barrier.

The donor-funded and humanitarian supply agent serves international agencies, non-governmental organisations and relief programmes. Dubai's established role as a humanitarian logistics hub makes this a genuine specialism rather than an occasional order, and its distinguishing features are audited procurement rules, strict product and packaging specifications, and buyers who pay reliably but slowly.

The group trading arm exists so that a manufacturing or distribution group can route third-country sales, treasury and contracting through one company. Here the licence is a structural instrument rather than a standalone business.

CZ 364 — Trading In Pharmaceutical Product (Outside UAE)

The line covers buying and selling finished pharmaceutical products on the company's own account or on commission, where title passes outside the UAE. In practice the work is documentary and logistical rather than physical: negotiating with manufacturers and buyers, raising back-to-back contracts, opening and accepting letters of credit and other documentary payment terms, arranging freight, insurance and third-country shipment, assembling the certificates and attestations an importing authority asks for, and managing the gap between paying a supplier and being paid by a buyer.

Three things dominate the operating risk, and none is a licensing matter.

The export permission at the far end. Many countries control the export of medicines and require documents — certificates of a product's status in its home market, attestations of manufacture, batch certificates — that only the manufacturer or its own authority can issue. A trader who has agreed a delivery date without confirming that those exist has sold something he cannot yet ship.

The import permission at the receiving end. Every importing country decides for itself which products may enter, in what packaging, in which language, with what shelf life remaining, and through which licensed importer. A consignment refused on arrival is a consignment that has to be stored, re-exported or destroyed at somebody's cost, and the contract decides whose.

The condition of the goods in transit. Temperature-sensitive product does not announce a failure. A shipment that lost its cold chain in a transit shed looks identical to one that did not, and the entire value of the consignment depends on a temperature record nobody can reconstruct afterwards. Monitored packaging, data loggers and a documented chain of custody are the only defence, and they are bought before the shipment moves.

Where a transaction sits structurally depends on what the goods do, and that is worth reading as a routing question rather than a licensing preference.

The marked row is the activity this licence is for, and the two mainland rows are the ones that catch people. The distinction the drawing turns on is not where the invoice is raised or where the money is received. It is where the goods are sold. A transaction that ends with a medicine in a UAE pharmacy is local trade in medicines no matter how the paperwork is arranged, and it requires the product itself to have been permitted for this market — which is the single most expensive thing to discover after a container has arrived.

What the licence does not cover

It does not permit selling into the UAE market. Not to a pharmacy, not to a hospital, not to a local distributor, not as a favour at the end of a cancelled export order. That is the whole meaning of the words in brackets.

It does not permit holding stock in the mainland for local sale. Goods in a customs-controlled facility awaiting re-export are in transit; the same goods moved into a mainland warehouse against a local order are something else.

It does not permit storage or transit without the right warehousing arrangement. If consignments will physically rest here, that is a facility question with its own conditions, and medicines are not a commodity any available warehouse can hold.

It does not permit manufacturing, repacking, relabelling or re-sterilising. Changing a carton to suit a destination market's language requirement is production work, and doing it quietly in a transit store is among the more serious things that go wrong in this trade.

And it does not relieve the company of the exporting and importing countries' rules. No UAE licence can. Those two permissions are the real constraints on this business, they are confirmed country by country and product by product, and the honest position is that they are commercial due diligence rather than something an adviser here can grant.

What the licence costs to hold, which zone and which wording suit a particular trading pattern, and what arrangements are available for goods that will physically transit depend on the authority and the facility. ConsultZone confirms those for the specific case.

References

1. Ministry of Health and Prevention — medicines and health products, and what may be placed on the UAE market, which is the boundary this licence stops at. Ministry of Health and Prevention
2. Dubai Customs — import, export, re-export and transit, customs codes, and goods restricted or prohibited on entry. Dubai Customs
3. UAE Government portal — federal law, trade policy and general government information. UAE Government portal
4. Ministry of Economy — commercial agency arrangements, intellectual property and company matters relevant to third-country trade. Ministry of Economy
5. Federal Tax Authority — VAT and corporate tax enrolment and filing, and the treatment of goods that do not enter the local market. Federal Tax Authority